Design of a project for the research and development of bioproducts and 3D printing strategies for the personalised, curative and preventive treatment of osteoarthritis (OA)

biOAdin
Project details

Abbreviation: biOAdin

Start date: 2025-01-01End date: 2027-12-31

Budget: 186.401 €

Centre bugdet: 154.337 €

Description

An ageing population has led to an increase in the prevalence of degenerative diseases such as osteoarthritis, which affects more than 528 million people worldwide and represents a significant socio-economic and public health challenge. Osteoarthritis is a multifactorial condition characterised by the progressive degradation of articular cartilage, with genetic, mechanical and cellular factors – such as senescence – contributing to its development. Despite advances in diagnostic techniques and cell therapies, there is still no cure or treatment capable of halting its progression.

This project aims to develop a tissue engineering strategy for osteochondral regeneration based on advanced biomaterials. The proposal involves the use of semi-interpenetrating (semi-IPN) and/or interpenetrating (IPN) networks of alginate and hyaluronic acid, with and without a decellularised cartilage matrix (dECM), as functional hydrogels, combined with 3D-printed polymeric scaffolds to improve mechanical stability and structural integration. In addition, the incorporation of bioceramics such as hydroxyapatite for bone regeneration will be explored.

The proposal aims to provide a reproducible, scalable and translational solution for the repair of joint tissues, contributing to the development of effective and personalised therapies for osteoarthritis.

Participants
  • Leartiker 
  • Biogipuzkoa
Activities carried out by Leartiker

1. Production of three-dimensional (3D) alginate and hyaluronic acid hydrogels as matrix substitutes for damaged articular cartilage, with and without dECM

  • Development of semi-IPN and/or IPN hydrogels based on alginate and hyaluronic acid with dECM (dH3D) and without dECM (H3D)
  • To assess the printability of the hydrogels
  • To assess the hydrogels’ suitability as 3D scaffolding (degradation and cytotoxicity assays)
  • In vitro mechanical evaluation of the hydrogels with chondrocytes



2.- Production of 3D composite scaffolds (SC3D) from bioactive polymeric materials as functional bone repair grafts

  • Production of different composites using compounding technology
  • Monitoring the quality of materials during processing and manufacture
  • Design and manufacture of 3D-printed bone composites
  • Assessing the mechanical behaviour, biocompatibility and bioactivity of 3D-printed bone composites



3.- Validation process for hybrid biomimetic constructs such as osteochondral scaffolds designed using tissue engineering

  • Fabrication of osteochondral units by combining composite scaffolds and 3D hydrogels
  • In vitro mechanical evaluation of osteochondral constructs combining composite scaffolds and hydrogels with chondrocytes
USE OF COOKIES

This website uses its own and third-party cookies in order to offer you the best possible user experience.

Before continuing, you must decide what to do with these cookies. You can accept all or save the selection you make.

OWN COOKIES

We use the technical cookies necessary for the operation of the website and we save your preferences for cookie settings and chosen language.

THIRD PARTY COOKIEES

We use third-party sites to analyze browsing and to display embedded information (YouTube and Flickr). Activate the desired options.

Not accepting third-party cookies will mean that we do not show you certain content. Although we will show you a link to access them.

For more information see: Privacy policy